Sequella
Manufacturing · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9610 Medical Center Dr Ste 200, Rockvill...Phone Number
(301) 762-7776Website
www.sequella.comRevenue
<$5 MillionIndustry
About Sequella
Sequella is a clinical-stage pharmaceutical company focused on developing innovative antibiotics to combat drug-resistant bacterial, fungal, and parasitic infections. Their product pipeline targets significant global health issues, particularly tuberculosis (TB) and its multidrug-resistant forms, which impact over 3 billion people worldwide. With drug candidates like SQ109 and sutezolid having completed phase 2 clinical trials, Sequella aims to address the urgent need for effective treatments in this area. The company also explores therapies for other serious infections, including those caused by Clostridium difficile and various parasitic diseases.Explore more
Sequella Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Sequella
Compare insights from companies similar to Sequella, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$43M
11-50
Public
$306.6M
2013
Sequella Tech Stack
A closer look at the technologies used by Sequella
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sequella
Sign Up For FreeTo access detailed company insights
Sequella is a clinical-stage pharmaceutical company focused on developing innovative antibiotics to combat drug-resistant bacterial, fungal, and parasitic infections. Their product pipeline targets significant global health issues, particularly tuberculosis (TB) and its multidrug-resistant forms, which impact over 3 billion people worldwide. With d... Read More
